Allopurinol in the treatment of visceral leishmaniasis
- 1 January 1981
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 75 (4) , 556-559
- https://doi.org/10.1016/0035-9203(81)90198-x
Abstract
Allopurinol was used in the treatment of 10 patients with kala-azar. Of six patients who had previously failed to respond satisfactorily to PentostamKeywords
This publication has 6 references indexed in Scilit:
- RENAL CLEARANCE OF PENTAVALENT ANTIMONY (SODIUM STIBOGLUCONATE)The Lancet, 1980
- Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.Journal of Biological Chemistry, 1979
- Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.Journal of Biological Chemistry, 1979
- Antitrypanosomal Effect of Allopurinol: Conversion in Vivo to Aminopyrazolopyrimidine Nucleotides by Trypanosoma cruziScience, 1978
- Antileishmanial Effect of Allopurinol. II. Relationship of Adenine Metabolism in Leishmania Species to the Action of AllopurinolThe Journal of Infectious Diseases, 1977
- Antileishmanial Effect of AllopurinolAntimicrobial Agents and Chemotherapy, 1974